Answers are grounded in this paper and cite their sources.
Retrospective cohort study demonstrates a non-invasive tool predicting liver events in advanced disease, indicating its utility in risk stratification.
HVPG-3P is a simple tool for non-invasive prediction of endoscopic signs of PH and could be used to stratify the risk of LRE in ACLD patients.
No takes yet. Share an insight, caveat, or question.
Capasso et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: